Skip to main content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.covid19.nih.gov/

Division of Cancer Prevention
Division of Cancer Prevention

Search form

Main menu

  • Home
  • Major Programs
    • Cancer Prevention Fellowship Program (CPFP)
    • Early Detection Research Network (EDRN)
    • NCI Community Oncology Research Program (NCORP)
    • Alliance of Glycobiologists for Cancer Research
    • Barrett's Esophagus Translational Research Network (BETRNet)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Consortium for Imaging and Biomarkers (CIB)
    • Liquid Biopsy Consortium
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Small Cell Lung Cancer (SCLC) Consortium
    • Supportive Care and Symptom Management
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
    • Research Networks Map
  • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials Search
    • Landmark Trials
    • Clinical Trials Management
  • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
  • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System
  • News & Events
    • News
    • Blog
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • Scientific Scope
    • Director
    • DCP Leadership
    • History and Timeline
    • Historical Resources
    • Staff Directory

You are here

  1. Home
  2.   »  Research Groups
  3.   »  Biometry

Biometry

Research Groups

  • Biometry
    • About the Biometry Research Group
    • Measurement Error: Impact on Nutrition Research and Adjustment for its Effects
    • Interactive Diet and Activity Tracking in AARP (IDATA) Study Data
    • Clinical Trial Randomization Tool
    • Meetings and Events
    • Power Program
    • Publications
    • Staff
  • Breast and Gynecologic Cancer
  • Cancer Biomarkers
  • Chemopreventive Agent Development
  • Community Oncology and Prevention Trials
  • Early Detection
  • Gastrointestinal and Other Cancers
  • Lung and Upper Aerodigestive Cancer
  • Nutritional Science
  • Prostate and Urologic Cancer

Contact the Biometry Research Group

Phone: 240-276-7020
Fax: 240-276-7845

For Regular Mail

Biometry Research Group, DCP
National Cancer Institute
9609 Medical Center Drive
MSC 9789
Bethesda, MD 20892-9789

For Courier Packages

Biometry Research Group, DCP
National Cancer Institute
9609 Medical Center Drive
Rockville, MD 20850

The Biometry Research Group contributes to the rigor and reproducibility of cancer prevention research through statistical consultation and methodologic development.

Read more About the Biometry Research Group.

Staff

Publications

Meetings and Events

Measurement Error: Impact on Nutrition Research and Adjustment for its Effects

A primer on statistical issues and methods to analyze data that are subject to measurement error.

Interactive Diet and Activity Tracking in AARP (IDATA) Study Data

Device-based and intensive self-report physical activity and diet data with biomarkers.

Clinical Trial Randomization Tool

Create randomized arm allocation sequences for any real-world trial, using the maximally tolerated imbalance method.

Power Program

Compute sample size or power for a variety of experimental designs.

Follow us at:

@NCIPrevention

@NCISymptomMgmt

@NCICastle

The National Cancer Institute

Policies

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

NCI's PDQ® Evidence-based Summaries

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

General Information

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®